Prostascint® scan: contemporary use in clinical practiceIndium In 111 capromab pendetide (ProstaScint®; Cytogen Corporation, Princeton, NJ), a radiolabeled monoclonal antibody to prostate-specific membrane antigen, offers a potential means of localizing...
Targeting human prostate cancer with in-111-labeled d2b igg, f(ab ')(2) and fab fragments in nude mice with psma-expressing xenografts... The optimal time point for imaging was determined in biodistribution and microSPECT imaging studies with In-111-D2B IgG, In-111-capromab pendetide, In-111-D2B F(ab)(2) and In-111-D2B Fab fragments in mice with PSMA-expressing LNCaP and PSMA-negative PC3 tumors at several time points after injection....
Targeting human prostate cancer with (111) in-labeled d2b igg, f(ab')2 and fab fragments in nude mice with psma-expressing xenografts... The optimal time point for imaging was determined in biodistribution and microSPECT imaging studies with (111) In-D2B IgG, (111) In-capromab pendetide, (111) In-D2B F(ab')2 and (111) In-D2B Fab fragments in mice with PSMA-expressing LNCaP and PSMA-negative PC3 tumors at several time points after injection....
Correction of photon attenuation and collimator response for a body-contouring spect/ct imaging system111In-Capromab pendetide imaging is indicated for postpros-tatectomy patients at risk for residual or recurrent disease....
